Simpler Grants.gov #PAR-26-093

NIH Grant for Exploratory Clinical Neuroscience Research on Substance Use Disorders

This opportunity from the National Institutes of Health (NIH) supports exploratory and developmental clinical neuroscience research on substance use disorders (SUD): - Issued by the Division of Neuroscience and Behavior (DNB) at NIH - Utilizes the R61/R33 Phased Innovation Award mechanism for projects requiring larger budgets than the R21 mechanism allows - Focuses on research into the neurobiological mechanisms underlying SUD, emphasizing fundamental brain function - Open to a wide range of applicants, including government agencies, nonprofits, businesses, and educational institutions - No specific Original Equipment Manufacturers (OEMs) or vendors are named, as this is a grant for research activities rather than a procurement of products - No unique product or service requirements beyond the focus on clinical neuroscience research related to SUD

Description

This Notice of Funding Opportunity (NOFO) uses a R61/R33 Phased Innovation Award mechanism to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental brain function relevant to substance use. It is designed to support exploratory/developmental projects requiring budgets exceeding those allowed for the R21 mechanism. The funding supports research to understand neurobiological mechanisms underlying SUD. The award is a grant with no cost sharing or matching requirement.

View original listing